Your browser doesn't support javascript.
loading
A launch vector for the production of vaccine antigens in plants.
Musiychuk, Konstantin; Stephenson, Natalie; Bi, Hong; Farrance, Christine E; Orozovic, Goran; Brodelius, Maria; Brodelius, Peter; Horsey, April; Ugulava, Natalia; Shamloul, Abdel-Moneim; Mett, Vadim; Rabindran, Shailaja; Streatfield, Stephen J; Yusibov, Vidadi.
Afiliação
  • Musiychuk K; Fraunhofer USA Center for Molecular Biotechnology, 9 Innovation Way, Newark, DE 19711, USA. vyusibov@fraunhofer-cmb.org
Influenza Other Respir Viruses ; 1(1): 19-25, 2007 Jan.
Article em En | MEDLINE | ID: mdl-19453476
Historically, most vaccines have been based on killed or live-attenuated infectious agents. Although very successful at immunizing populations against disease, both approaches raise safety concerns and often have limited production capacity. This has resulted in increased emphasis on the development of subunit vaccines. Several recombinant systems have been considered for subunit vaccine manufacture, including plants, which offer advantages both in cost and in scale of production. We have developed a plant expression system utilizing a 'launch vector', which combines the advantageous features of standard agrobacterial binary plasmids and plant viral vectors, to achieve high-level target antigen expression in plants. As an additional feature, to aid in target expression, stability and purification, we have engineered a thermostable carrier molecule to which antigens are fused. We have applied this launch vector/carrier system to engineer and express target antigens from various pathogens, including, influenza A/Vietnam/04 (H5N1) virus.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plantas Geneticamente Modificadas / Vacinas de Subunidades Antigênicas / Vetores Genéticos / Antígenos Limite: Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plantas Geneticamente Modificadas / Vacinas de Subunidades Antigênicas / Vetores Genéticos / Antígenos Limite: Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article